Table 2—

Age-and sex-adjusted rates of hypertension, elevated levels of LDL, and type 2 diabetes, as well as treatment and control, among BMI categories

BMI 18.5 to <25 kg/m2BMI 25 to <30 kg/m2BMI ≥30 kg/m2P value*
n2,4582,5961,747
Hypertension
    Prevalence11.5 (10.2–12.9)22.8 (21.0–24.8)37.6 (34.5–40.7)<0.001
    Treatment58.7 (49.8–67.1)59.0 (52.8–65.0)62.3 (56.1–68.2)0.002
    Control36.7 (30.3–43.5)37.3 (32.7–41.9)39.4 (34.9–44.0)0.48
Elevated LDL cholesterol levels
    Prevalence12.7 (11.3–14.2)28.2 (26.2–30.4)35.1 (32.2–38.2)<0.001
    Treatment34.2 (28.2–40.6)36.4 (32.3–40.6)39.5 (34.9–44.4)0.02
    Control26.7 (21.5–32.4)26.0 (22.6–29.7)29.2 (25.3–33.4)0.11
Diabetes
    Prevalence1.4 (0.9–1.9)4.1 (3.4–5.0)11.9 (10.3–13.6)<0.001
    Treatment69.2 (38.6–90.9)50.0 (35.2–64.8)55.0 (44.7–65.0)0.54
    A1C <7.0%50.0 (18.7–81.3)58.8 (40.7–75.4)47.7 (35.3–59.4)0.26
    Fasting plasma glucose <126 mg/dl30.4 (13.2–52.9)20.7 (12.8–30.7)15.7 (10.8–21.7)0.02
  • Data are % of participants (95% CI). SI conversion factor: To convert fasting plasma glucose to millimoles per liter, multiply milligrams per deciliter values by 0.0555.

  • *

    * Global GEE P value.

  • Data available for Offspring cohort only.